Big Pharma Wants to Pocket the Profits From a COVID Treatment You Already Paid For
Why Gilead’s price gouging for its Covid-19 treatment remdevisir is even more egregious than you thought.
Read more...Why Gilead’s price gouging for its Covid-19 treatment remdevisir is even more egregious than you thought.
Read more...Deutsche Bank revealed again as being overly accommodating to clients who play fast and loose….this one Jeffrey Epstein.
Read more...Quelle suprise! E-money is facilitating financial fraud. And the UK’s FCA is unduly accommodating.
Read more...A nurse speaks from one of the Covid-19 mask battlegrounds.
Read more...Universities face an anxious and meager school year.
Read more...The World Economics Forum asks for trouble next year, both ideologically and institutionally.
Read more...Why the risk of nuclear war has been and remains much higher than you realize.
Read more...Looking at some underrated Trump weaknesses.
Read more...Drug price gouging is so widespread in the US that it seems unlikely that there will be enough outrage to limit coronavirus drug price gouging.
Read more...A hard look at charter school misleading ads, racial segregation, and dodgy economics.
Read more...CalPERS vice president and Investment Committee chairman Theresa Taylor had engaged in an apparent clear cut perjury by failing to disclose income.
Read more...Why using credit as an economic remedy evenutally does more harm than good.
Read more...Boris Johnson’s effort at a New Deal Big Lie goes splat.
Read more...How Arizona epitomizes the backwards approach the US has taken to its health care crisis.
Read more...WSJ says banks can no longer determine who is credit-worthy using existing models – more COVID-19 fallout, this of uncertain magnitude.
Read more...